Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease (AFIRE)
Thank you Nikita for leading us through a discussion of the AFIRE trial.
Clinical Question:
In patients with atrial fibrillation and stable CAD >1 year after revascularization (or confirmed CAD on angiography not requiring revascularization), how does rivaroxaban monotherapy compare to rivaroxaban plus an antiplatelet agent in terms of efficacy and safety?
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction (MADIT-II)
In this article, we review how prophylactic implantation of defibrillator decreases mortality in patients with advanced LV dysfunction following prior MI.
Morning report – High-Output Heart Failure
Thank you to Dr. Thetford for presenting a rare case of TIPS induced high output heart failure. A few take away points: HOHF is a rare form of heart failure caused by increased CO and decreased SVR Common causes: Obesity,…
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (ROCKET-AF)
Randomized Trial of Colchicine for Acute Pericarditis
Let's review: General treatment options for acute pericarditis include: NSAID's Colchicine Prednisone Read this article to learn which agent or combination of agents has more benefit.
Strategies for Multivessel Revascularization in Patients with Diabetes (FREEDOM)
What treatment is recommend for diabetic patients with 3-vessel coronary artery disease? Review this landmark article to find the evidence for multivessel CAD treatment recommendations in diabetes.